CNTX Financials

Context Therapeutics Inc - Financial statements & key metrics

Stock Price

$0.38

Market Cap

$55.13M

P/E Ratio

-0.8

EPS

$-0.24

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-26.73M

EPS (Diluted)

$-0.46

Balance Sheet Highlights

Total Assets

$98.13M

Total Liabilities

$2.86M

Shareholders Equity

Cash & Equivalents

$94.43M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-14.56M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-33.7%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CNTX revenue?

View CNTX's income statement for detailed revenue data.

Is CNTX profitable?

CNTX reported a loss of $26.73M in the most recent quarter.

What is CNTX market cap?

CNTX has a market capitalization of $55.13M, making it a small-cap stock.

Does CNTX have debt?

View CNTX's balance sheet for debt information.

What is CNTX cash flow?

Cash flow data is available in the full financial statements.